For moderately preterm infants, extending the caffeine treatment often used for apnea of prematurity for 28 days after discharge did not help them get home from the hospital sooner, the MoCHA ...

has granted Breakthrough Device Designation to explore the use of its proprietary stimulation to treat apnea of prematurity (AOP), a cessation of breathing for 20 seconds or longer and a major ...

Greenberg and colleagues enrolled 223 hospitalized premature infants who were born before 33 weeks gestation. At two months of age, roughly half the babies were randomly assigned to receive the ...

ENA-001, with a novel mechanism of action as an agnostic respiratory stimulant, has previously been granted Rare Pediatric Disease Designation for the treatment of Apnea of Prematurity by the FDA ...

Every year, about 1.6 million preterm newborns experience apnea of prematurity, or episodes where they stop breathing for more than 20 seconds or 10 seconds, followed by a slow heartbeat.